179 results
F-1
EX-10.5
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
(“BioLine”), and Phillip Serlin, I.D. Number 310550157 with an address at 11 Hachazav Street, Bet Shemesh (the “Employee”).
WHEREAS, BioLine desires … to employ the Employee and the Employee desires to enter into such employment, on the terms and conditions hereinafter set forth.
NOW THEREFORE
F-1
EX-10.21
BLRX
Bioline Rx Ltd
24 Sep 10
Registration statement (foreign)
12:00am
with an address at 44 Metudela Street, Tel Aviv 69867 (the “Employee”).
WHEREAS, the Employee and BioLine Innovations Jerusalem, L.P., a limited … ”), which Employment Agreement replaced the previous Engagement Offer entered into between BioLine and the Employee, dated May 6, 2004;
WHEREAS
20FR12B
EX-4.20
BLRX
Bioline Rx Ltd
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
with an address at 44 Metudela Street, Tel Aviv 69867 (the “Employee”).
WHEREAS, the Employee and BioLine Innovations Jerusalem, L.P., a limited … ”), which Employment Agreement replaced the previous Engagement Offer entered into between BioLine and the Employee, dated May 6, 2004;
WHEREAS, the Employee
20FR12B
EX-4.5
8xa20kigeykw whsn
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.1
em4xfswgippxz1jp5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.2
ufssxfu1go8pl79zz8we
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.2
e5l kxku5e3a
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.22
wrg m67hh
24 Sep 10
Registration statement (foreign)
12:00am
F-1
EX-10.1
l8hvr nj2l0
24 Sep 10
Registration statement (foreign)
12:00am
20FR12B
EX-4.21
o5klq2rhn
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.3
2uzgxf a0
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.3
xkat2 hkb2p
24 Sep 10
Registration statement (foreign)
12:00am
6-K
EX-99
tqupsm
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am